MK-0159
MK-0159 is a potent, orally bioavailable small molecule inhibitor of CD38, developed for research into cardiac ischemia-reperfusion injury (IRI) . It demonstrates cardioprotective effects by mitigating myocardial damage, making it a valuable tool for in vivo and in vitro studies of cardiovascular disease and CD38-related pathways.
Product Specifications
CAS Number
2641484-61-7
Product Name Alternative
CD38
Field of Research
Immunology & Inflammation
Purity
98.05% (May vary between batches)
Solubility
DMSO:80 mg/mL (199.75 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.24 mM)
Smiles
COCCO[C@H]1CC[C@@H] (CC1) NC (=O) c1cc (nc2[nH]ccc12) -c1cncs1
Molecular Formula
C20H24N4O3S
Molecular Weight
400.495
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6288976-01 0.1 mL
CRTC2, CT (CRTC2, TORC2, CREB-regulated transcription coactivator 2, Transducer of regulated cAMP response element-binding protein 2) (MaxLight 750)
Sign In for Pricing
View Details MBS6288976-02 5x 0.1 mL
CRTC2, CT (CRTC2, TORC2, CREB-regulated transcription coactivator 2, Transducer of regulated cAMP response element-binding protein 2) (MaxLight 750)
Sign In for Pricing
View Details